These signals favor the recruitment of antigen presenting cells (APCs) such as dendritic cells (DCs), promote uptake of dying tumor cells, and enhance TAA processing and the cross-presentation of antigenic peptides via major histocompatibility complex (MHC) class I to CD8+ T cells, promoting an adaptive immune response (16). This evidence concerns the gene CD8A and neoplasm.